Immunoglobulin therapy and thrombosis: coincidence or causation?


T he development of intravenous (IV) immune globulin (IVIG) in 1979 represented a revolution in the treatment of primary immune deficiency. Over the past three decades, the uses (both labeled and off-labeled) have expanded dramatically including widespread use both for transferring passive immunity and for its pleomorphic immunomodulatory effects. While… (More)
DOI: 10.1111/j.1537-2995.2012.03868.x


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics